Prof Dr David Capper has been appointed as Professor for Molecular Neuropathology (W2) of the German Cancer Consortium (DKTK) at the Charité Berlin since the 1st of April.
Previously, David Capper worked as senior physician of Neuropathology at the University Hospital Heidelberg and was member of the Clinical Cooperation Unit Neuropathology at the German Cancer Research Center (DKFZ). His research focuses on the Pathology and genetics of tumors of the central nervous system with a special focus on the development of specific diagnostic markers ("mutation-specific monoclonal antibody") and classification of brain tumors by genome-wide analysis of DNA methylation patterns. For several national and international studies such as the INFORM register study he headed the central pathology. As part of the DKTK he will promote the construction of a pipeline for the analysis of tumor methylation patterns, which influence the genetic activity of tumor cells.
Back to Overview